These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9067094

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chemoattractant receptors for interleukin-8 and C5a: expression on peripheral blood leukocytes and differential regulation on HL-60 and AML-193 cells by vitamin D3 and all-trans retinoic acid.
    Zahn S, Zwirner J, Spengler HP, Götze O.
    Eur J Immunol; 1997 Apr; 27(4):935-40. PubMed ID: 9130647
    [Abstract] [Full Text] [Related]

  • 3. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor.
    Chuntharapai A, Kim KJ.
    J Immunol; 1995 Sep 01; 155(5):2587-94. PubMed ID: 7650389
    [Abstract] [Full Text] [Related]

  • 4. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.
    Ahuja SK, Lee JC, Murphy PM.
    J Biol Chem; 1996 Jan 05; 271(1):225-32. PubMed ID: 8550564
    [Abstract] [Full Text] [Related]

  • 5. Functional and ligand binding specificity of the rabbit neutrophil IL-8 receptor.
    Thomas KM, Taylor L, Prado G, Romero J, Moser B, Car B, Walz A, Baggiolini M, Navarro J.
    J Immunol; 1994 Mar 01; 152(5):2496-500. PubMed ID: 8133060
    [Abstract] [Full Text] [Related]

  • 6. The differential ability of IL-8 and neutrophil-activating peptide-2 to induce attenuation of chemotaxis is mediated by their divergent capabilities to phosphorylate CXCR2 (IL-8 receptor B).
    Ben-Baruch A, Grimm M, Bengali K, Evans GA, Chertov O, Wang JM, Howard OM, Mukaida N, Matsushima K, Oppenheim JJ.
    J Immunol; 1997 Jun 15; 158(12):5927-33. PubMed ID: 9190946
    [Abstract] [Full Text] [Related]

  • 7. The interleukin-8 receptor B and CXC chemokines can mediate transendothelial migration of human skin homing T cells.
    Santamaria Babi LF, Moser B, Perez Soler MT, Moser R, Loetscher P, Villiger B, Blaser K, Hauser C.
    Eur J Immunol; 1996 Sep 15; 26(9):2056-61. PubMed ID: 8814246
    [Abstract] [Full Text] [Related]

  • 8. Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils but interact in different ways. Discrepancies in binding affinities, receptor densities, and biologic effects.
    Petersen F, Flad HD, Brandt E.
    J Immunol; 1994 Mar 01; 152(5):2467-78. PubMed ID: 8133058
    [Abstract] [Full Text] [Related]

  • 9. Functional and receptor binding characterization of recombinant murine macrophage inflammatory protein 2: sequence analysis and mutagenesis identify receptor binding epitopes.
    Jerva LF, Sullivan G, Lolis E.
    Protein Sci; 1997 Aug 01; 6(8):1643-52. PubMed ID: 9260277
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells.
    Lippert U, Artuc M, Grützkau A, Möller A, Kenderessy-Szabo A, Schadendorf D, Norgauer J, Hartmann K, Schweitzer-Stenner R, Zuberbier T, Henz BM, Krüger-Krasagakes S.
    J Immunol; 1998 Sep 01; 161(5):2600-8. PubMed ID: 9725262
    [Abstract] [Full Text] [Related]

  • 13. Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis.
    Quan JM, Martin TR, Rosenberg GB, Foster DC, Whitmore T, Goodman RB.
    Biochem Biophys Res Commun; 1996 Feb 15; 219(2):405-11. PubMed ID: 8605000
    [Abstract] [Full Text] [Related]

  • 14. Expression of interleukin-8 receptors on tumor cells and vascular endothelial cells in human breast cancer tissue.
    Miller LJ, Kurtzman SH, Wang Y, Anderson KH, Lindquist RR, Kreutzer DL.
    Anticancer Res; 1998 Feb 15; 18(1A):77-81. PubMed ID: 9568059
    [Abstract] [Full Text] [Related]

  • 15. Activation of human basophils through the IL-8 receptor.
    Krieger M, Brunner T, Bischoff SC, von Tscharner V, Walz A, Moser B, Baggiolini M, Dahinden CA.
    J Immunol; 1992 Oct 15; 149(8):2662-7. PubMed ID: 1383321
    [Abstract] [Full Text] [Related]

  • 16. IL-8 specifically binds to endothelial but not to smooth muscle cells.
    Schönbeck U, Brandt E, Petersen F, Flad HD, Loppnow H.
    J Immunol; 1995 Mar 01; 154(5):2375-83. PubMed ID: 7868904
    [Abstract] [Full Text] [Related]

  • 17. Multiple sites on IL-8 responsible for binding to alpha and beta IL-8 receptors.
    Schraufstätter IU, Barritt DS, Ma M, Oades ZG, Cochrane CG.
    J Immunol; 1993 Dec 01; 151(11):6418-28. PubMed ID: 8245475
    [Abstract] [Full Text] [Related]

  • 18. Physical association of Gi2alpha with interleukin-8 receptors.
    Damaj BB, McColl SR, Mahana W, Crouch MF, Naccache PH.
    J Biol Chem; 1996 May 31; 271(22):12783-9. PubMed ID: 8662698
    [Abstract] [Full Text] [Related]

  • 19. Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2.
    Feniger-Barish R, Ran M, Zaslaver A, Ben-Baruch A.
    Cytokine; 1999 Dec 31; 11(12):996-1009. PubMed ID: 10623425
    [Abstract] [Full Text] [Related]

  • 20. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor.
    Baly DL, Horuk R, Yansura DG, Simmons LC, Fairbrother WJ, Kotts C, Wirth CM, Gillece-Castro BL, Toy K, Hesselgesser J, Allison DE.
    J Immunol; 1998 Nov 01; 161(9):4944-9. PubMed ID: 9794430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.